![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Z Yu and JH McNeill
Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.
To understand the mechanisms of diabetic cardiomyopathy and the consequences of combined hypertension and diabetes, cardiac tissue responses to various inotropic agents were measured in experimental diabetes. Streptozotocin was injected into Wistar rats, spontaneously hypertensive rats (SHRs) and Wistar-Kyoto rats (WKYs). Six weeks after the injection diabetic rats showed a subsensitivity to beta adrenergic stimulation in ventricular tissue and a supersensitivity and hyper- responsiveness to Ca++ and alpha adrenergic stimulation (except in WKYs) in ventricular tissues and left atria. A supersensitivity to BAY K 8644 in SHR left atria and a hyper-responsiveness to verapamil in ventricular strips were also noted. These alterations may be due to a change in receptor number or to postreceptor alterations. Diabetic SHRs exhibited greater changes in several of the drug responses (responses to isoproterenol, phenylephrine and BAK 8644) were more hyperlipidemic and had a high mortality as compared with Wistar rats and WKY diabetics. These findings confirm that the combination of hypertension and diabetes results in greater cardiac pathology than is seen with either disease alone.
This article has been cited by other articles:
|
|
 |
|
  I. S. Harris, I. Treskov, M. W. Rowley, S. Heximer, K. Kaltenbronn, B. N. Finck, R. W. Gross, D. P. Kelly, K. J. Blumer, and A. J. Muslin G-Protein Signaling Participates in the Development of Diabetic Cardiomyopathy Diabetes, December 1, 2004; 53(12): 3082 - 3090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. D. Dinçer, K. R. Bidasee, S. Güner, A. Tay, A. T. Özçelikay, and V. M. Altan The Effect of Diabetes on Expression of {beta}1-, {beta}2-, and {beta}3-Adrenoreceptors in Rat Hearts Diabetes, February 1, 2001; 50(2): 455 - 461. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Tamada, Y. Hattori, H. Houzen, Y. Yamada, I. Sakuma, A. Kitabatake, and M. Kanno Effects of beta -adrenoceptor stimulation on contractility, [Ca2+]i, and Ca2+ current in diabetic rat cardiomyocytes Am J Physiol Heart Circ Physiol, June 1, 1998; 274(6): H1849 - H1857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Gando, Y. Hattori, Y. Akaishi, J. Nishihira, and M. Kanno Impaired Contractile Response to Beta Adrenoceptor Stimulation in Diabetic Rat Hearts: Alterations in Beta Adrenoceptors-G Protein-Adenylate Cyclase System and Phospholamban Phosphorylation J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 475 - 484. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. E. Christe and R. L. Rodgers Cardiac Glucose and Fatty Acid Oxidation in the Streptozotocin-Induced Diabetic Spontaneously Hypertensive Rat Hypertension, February 1, 1995; 25(2): 235 - 241. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
